Showing results (301-310 of 5,003) with videos related to

Sort By:
Pageof 501
American Journal of Clinical Oncology|August 14, 2009
A pilot prospective randomized trial of postoperative epoetin alfa in patients undergoing major operation for upper gastrointestinal malignancyStephen R Grobmyer, Alan W Hemming, Neil Harris, et al.
American Journal of Clinical Oncology|August 19, 2009
Phase II study of vinorelbine and docetaxel in the treatment of advanced non-small-cell lung cancer as frontline and second-line therapyWilliam N William, Fadlo R Khuri, Frank V Fossella, et al.
American Journal of Clinical Oncology|August 19, 2009
Pituitary adenoma: a radiotherapeutic perspectiveChristopher S Platta, Christopher Mackay, James S Welsh
American Journal of Clinical Oncology|August 19, 2009
Phase I study of hepatic arterial infusion of oxaliplatin in advanced hepatocellular cancer: a brown university oncology group studyRitesh Rathore, Howard Safran, Greg Soares, et al.
American Journal of Clinical Oncology|March 15, 2011
Randomized prospective phase II study to compare the combination chemotherapy regimen epirubicin, cisplatin, and 5-fluorouracil with epirubicin, cisplatin, and capecitabine in patients with advanced or metastatic gastric cancerJanja Ocvirk, Martina Reberšek, Erik Skof, et al.
American Journal of Clinical Oncology|March 8, 2011
Pulmonary rehabilitation in non-small cell lung cancer patients after completion of treatmentGeorg P Glattki, Katerina Manika, Lazaros Sichletidis, et al.
American Journal of Clinical Oncology|March 2, 2011
A Phase II trial of erlotinib as maintenance treatment after gemcitabine plus platinum-based chemotherapy in patients with recurrent and/or metastatic nasopharyngeal carcinomaBenoit You, Christophe Le Tourneau, Eric X Chen, et al.
American Journal of Clinical Oncology|March 2, 2011
Pathologic response to short intensified taxane-free neoadjuvant chemotherapy in patients with highly proliferative operable breast cancerChristophe Le Tourneau, Sarah Dettwiler, Philippe Beuzeboc, et al.
American Journal of Clinical Oncology|March 9, 2011
Is there a clinical benefit to adaptive planning during tomotherapy in patients with head and neck cancer at risk for xerostomia?Sei Hwan You, Song Yi Kim, Chang Geol Lee, et al.
American Journal of Clinical Oncology|March 9, 2011
Intravenous contrast agent influence on thoracic computed tomography simulation investigated through a heterogeneous dose calculation method using 5-bulk densitiesAnneyuko I Saito, Jonathan G Li, Chihray Liu, et al.
Pageof 501